ClinConnect ClinConnect Logo
Search / Trial NCT06897800

Vaginal Microbiota and Its Association with Pap Smear Results, Human Papillomavirus, Vitamins, and Metabolic Mark

Launched by CHENG-HSIN GENERAL HOSPITAL · Mar 26, 2025

Trial Information

Current as of April 23, 2025

Completed

Keywords

Vaginal Microbiome

ClinConnect Summary

Vaginal Microbiome, pH, Menopause, and Metabolic Factors

The human body is colonized by a vast array of symbiotic, commensal, and pathogenic microorganisms, including bacteria, fungi, and viruses. The relationship between these microorganisms and the host varies from mutualistic and commensal to pathogenic interactions, collectively referred to as the microbiome. The human microbiome resides on both external and internal surfaces of the body, playing a critical role in physiology, immune system development, digestion, and detoxification. The metagenome of bacterial populations within the h...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Participants must meet all of the inclusion criteria
  • Female participants
  • History of sexual activity
  • Age 30 years or older
  • Exclusion Criteria:
  • * Participants will be excluded from the study if they meet any of the following conditions:
  • Currently pregnant at the time of enrollment or before sample collection day.
  • History of total hysterectomy.

About Cheng Hsin General Hospital

Cheng-Hsin General Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust framework for conducting research, the hospital fosters collaboration among multidisciplinary teams to explore new therapeutic options and enhance clinical practices. By leveraging state-of-the-art facilities and a patient-centered approach, Cheng-Hsin General Hospital aims to contribute significantly to the medical community and drive forward the development of effective treatments across various health conditions.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported